tiprankstipranks
Trending News
More News >

Randy Milby Insider Profile

18 Followers
Randy Milby, CEO, Director at Cormedix, holds 17.53K shares in Tharimmune (Ticker: THAR), holds 403.27K shares in Cormedix (Ticker: CRMD). Most recently, Randy Milby Bought ― shares of Tharimmune on Dec 20, 2024 for an estimated value of $9.75K.
tipranks
Randy Milby

Randy Milby
Cormedix (CRMD)
CEO, Director

Ranked #94,146 out of 103,225 Corporate Insiders

Profitable Transactions

38%
12 out of 32 Profitable Transactions

Average Return

-14.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
98.20%
1.80%
A breakdown of Randy Milby's holdings

Insider Roles

Cormedix
(CRMD)
CEO, Director
Tharimmune
(THAR)
CEO, Director
Roles that Randy Milby holds in companies

Most Profitable Insider Trade

Stock:
Tharimmune
(THAR)
Rating:Informative Buy
Date:Oct 10, 2024 - Today
Return:+131.80%
The most profitable trade made by Randy Milby

Randy Milby's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cormedix
Aug 10, 2016
CEO, Director
Uninformative Buy
82.50K
$5.79M
Tharimmune
Dec 20, 2024
CEO, Director
Informative Buy
9.75K
$106.08K
List of latest transactions for each holding click on a transaction to see Randy Milby's performance on stock

Randy Milby insider profile FAQ

What is the percentage of profitable transactions made by Randy Milby?
The percentage of profitable transactions made by Randy Milby is 38%.
    What is the average return per transaction made by Randy Milby?
    The average return per transaction made by Randy Milby is -14.90%.
      What stocks does Randy Milby hold?
      Randy Milby holds: CRMD, THAR stocks.
        What was Randy Milby’s latest transaction?
        Randy Milby latest transaction was an Informative Buy of $9.75K.
          What was Randy Milby's most profitable transaction?
          Randy Milby’s most profitable transaction was an Informative Buy of THAR stock on October 10, 2024. The return on the trade was 131.80%.
            What is Randy Milby's role in Cormedix?
            Randy Milby's role in Cormedix is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.